Afrocentric InvestmentJSE:ACT 52 PB Ratio is 0.34 as of Jun. 27, 2026, which is 70% below its 10-year median of 1.12. GuruFocus rates JSE:ACT with a GF Score™ of 52/100 and a GF Value™ of R2.09 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 611 Healthcare Providers & Services companies, Afrocentric Investment ranks better than 96.73% on this metric.
The historical rank and industry rank for Afrocentric Investment's PB Ratio or its related term are showing as below:
JSE:ACT'
s PB Ratio Range Over the Past 10 Years
Min: 0.3 Med: 1.12 Max: 3.47
Current: 0.34
During the past 13 years, Afrocentric Investment's highest PB Ratio was 3.47. The lowest was 0.30. And the median was 1.12.
JSE:ACT's PB Ratio is ranked better than 96.73% of 611
companies
in the Healthcare Providers & Services industry
Industry Median: 1.98
vs JSE:ACT: 0.34
During the past 12 months, Afrocentric Investment's average Book Value Per Share Growth Rate was -41.50% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -18.10% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -7.20% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 3.80% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Afrocentric Investment was 29.10% per year. The lowest was -20.10% per year. And the median was 5.50% per year.
Back to Basics: PB Ratio
Afrocentric Investment (JSE:ACT) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Afrocentric Investment's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Afrocentric Investment PB Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Afrocentric Investment's PB Ratio distribution charts can be found below:
* The bar in red indicates where Afrocentric Investment's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Afrocentric Investment (JSE:ACT) has a PB Ratio of 0.34 as of Jun. 27, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Afrocentric Investment and its competitors. This is 70% below median its historical median of 1.12. Over the past decade, Afrocentric Investment's PB Ratio has ranged from 0.30 to 3.47. According to the industry distribution chart, Afrocentric Investment ranks #20 out of 611 companies in the Healthcare Providers & Services industry, placing it in the top 3.3%.
Is Afrocentric Investment's PB Ratio too high?
Afrocentric Investment's current PB Ratio of 0.34 is 70% below median its 10-year median of 1.12. Over the past 10 years, this metric has ranged from a low of 0.30 to a high of 3.47. The Healthcare Providers & Services industry median PB Ratio is 1.98. Afrocentric Investment's value of 0.34 is 82.8% below this industry median. Based on the distribution chart, Afrocentric Investment ranks #20 out of 611 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Afrocentric Investment has a GF Score™ of 52/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Afrocentric Investment's PB Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Afrocentric Investment ranks #20 out of 611 companies for PB Ratio. This places Afrocentric Investment in the top 3% of its industry — outperforming the majority of peers. The industry median PB Ratio is 1.98. Afrocentric Investment's value of 0.34 is 82.8% below this benchmark. Historically, Afrocentric Investment's own PB Ratio has ranged from 0.30 to 3.47 over the past decade. While the company's 10-year median is 1.12 vs. the industry median of 1.98, Afrocentric Investment has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 1.98, based on 611 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Afrocentric Investment's current PB Ratio of 0.34 is 82.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Afrocentric Investment and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 1.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Afrocentric Investment's current PB Ratio is 0.34, which is 70% below median its own 10-year median of 1.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Afrocentric Investment stock overvalued right now?
Based on GuruFocus' analysis, Afrocentric Investment (JSE:ACT) is currently considered Possible Value Trap. The stock's GF Value™ is R2.09, compared to a current price of R0.79 — trading 62.2% below its estimated fair value. The current PB Ratio is 0.34, which is 70% below median its 10-year median of 1.12 and 82.8% below the Healthcare Providers & Services industry median of 1.98. Afrocentric Investment's overall GF Score™ is 52/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Afrocentric Investment (JSE:ACT), the current PB Ratio is 0.34 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Afrocentric Investment (JSE:ACT) Overvalued in 2026?
Based on GuruFocus' analysis, Afrocentric Investment stock appears to be undervalued.
The current stock price of R0.79 is trading 62.2% below its estimated GF Value™ of R2.09.
GuruFocus considers Afrocentric Investment to be Possible Value Trap.
Key valuation signals for JSE:ACT:
PB Ratio: 0.34 (70% below median its 10-year median of 1.12)
GF Value™: R2.09 vs. price of R0.79 (62.2% below fair value)
Industry Position: 82.8% below the Healthcare Providers & Services median (#20 of 611)
No single metric tells the full story. See the JSE:ACT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Afrocentric Investment Corp Ltd is an investment holding company providing specialised services and products to the public and private healthcare sectors. It focuses on making quality healthcare accessible and affordable to members and beneficiaries, with the principal objective of ensuring the delivery of efficient health management services and the distribution of quality products. Its business segments include Healthcare SA, comprising medical scheme administration and health risk management services; Healthcare Retail, comprising pharmaceutical sales and services; Healthcare Africa, comprising healthcare services outside South Africa in Namibia and Mauritius; and IT-related services predominantly within South Africa. It operates across South Africa, Botswana, Mauritius, and Namibia.
52GF Score
Get the complete analysis for JSE:ACT
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JSE:ACT has been successfully added to your 
